All-cause mortality significantly lower with GLP-1 RA use, with consistent benefit across major cancer types, most GLP-1 RA types ...

Pharmacy benefit managers (PBMs) have used market leverage to demand rebates, which can lead drug manufacturers to increase sticker prices.

Investigators sought to determine whether adding gedatolisib to fulvestrant, with or without palbociclib, improved clinical outcomes in patients with HR-positive/HER2-negative/PIK3CA wild-type ...

There were 3.3 deaths per 100,000 live births. The rate was highest among non-Hispanic Black women, and researchers found significant variance by geographic region.

In this study, researchers aimed to determine associations between exposure to microplastics and lung cancer mortality in ever smokers.